Liver Diseases Therapeutics Market, Therapy Type (Anti-Rejection Drugs/Immunosuppressant’s, Chemotherapy Drugs, Targeted therapy, Vaccines, Anti-Viral Drugs, Immunoglobulin’s, Corticosteroids), By Distribution Channel (Hospital Pharmacies, Retail Pharmaci

Liver Diseases Therapeutics Market, Therapy Type (Anti-Rejection Drugs/Immunosuppressant’s, Chemotherapy Drugs, Targeted therapy, Vaccines, Anti-Viral Drugs, Immunoglobulin’s, Corticosteroids), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Liver Diseases Therapeutics are used for treatment of hepatitis A, hepatitis B, and hepatitis C; liver fibrosis, liver cancer; fatty liver disease and cirrhosis; hemochromatosis and Wilson disease. Increasing prevalence of liver diseases such as liver fibrosis is expected to propel growth of the global liver diseases therapeutics market over the forecast period. Other factors influencing the growth of the market constitute of growing prevalence of risk factors such as chronic infection with hepatitis B or C virus, compromised immune system due to co-infection with HIV or use of immunosuppressive drugs after a liver transplant.
Furthermore, Increasing R&D of novel therapeutics for treatment of liver diseases is expected to offer lucrative growth opportunities for players in the global liver diseases therapeutics market
Key features of the study:
This report provides in-depth analysis of the Liver Diseases Therapeutics market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global Liver Diseases Therapeutics market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Astellas Pharma Inc., Bristol-Myers Squibb, Gilead Sciences, Glaxosmithkline Plc, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Sanofi S.A, Pfizer Inc., Takeda Pharmaceutical, Valeant Pharmaceuticals, Watson Pharmaceuticals, Inc., Theratechnologies Inc., Alnylam Pharmaceuticals, Inc., Protagonist Therapeutics, Inc., Dicerna Pharmaceuticals, Inc., Endo International, Provectus Biopharmaceuticals Inc., and MAX BioPharma, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global Liver Diseases Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Liver Diseases Therapeutics market
Detailed Segmentation:
Liver Diseases Therapeutics Market, Therapy Type:
Anti-Rejection Drugs/Immunosuppressant’s
Chemotherapy Drugs
Targeted therapy
Vaccines
Anti-Viral Drugs
Immunoglobulin’s
Corticosteroids
Liver Diseases Therapeutics Market, By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Liver Diseases Therapeutics Market, By Region:
North America
Therapy Type:
Anti-Rejection Drugs/Immunosuppressant’s
Chemotherapy Drugs
Targeted therapy
Vaccines
Anti-Viral Drugs
Immunoglobulin’s
Corticosteroids
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.S.
Canada
Latin America
Therapy Type:
Anti-Rejection Drugs/Immunosuppressant’s
Chemotherapy Drugs
Targeted therapy
Vaccines
Anti-Viral Drugs
Immunoglobulin’s
Corticosteroids
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Therapy Type:
Anti-Rejection Drugs/Immunosuppressant’s
Chemotherapy Drugs
Targeted therapy
Vaccines
Anti-Viral Drugs
Immunoglobulin’s
Corticosteroids
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
Therapy Type:
Anti-Rejection Drugs/Immunosuppressant’s
Chemotherapy Drugs
Targeted therapy
Vaccines
Anti-Viral Drugs
Immunoglobulin’s
Corticosteroids
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Therapy Type:
Anti-Rejection Drugs/Immunosuppressant’s
Chemotherapy Drugs
Targeted therapy
Vaccines
Anti-Viral Drugs
Immunoglobulin’s
Corticosteroids
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
GCC
Israel
Rest of Middle East
Africa
Therapy Type:
Anti-Rejection Drugs/Immunosuppressant’s
Chemotherapy Drugs
Targeted therapy
Vaccines
Anti-Viral Drugs
Immunoglobulin’s
Corticosteroids
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
South Africa
Central Africa
North Africa
Company Profiles
Astellas Pharma Inc. *
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Bristol-Myers Squibb
Gilead Sciences
Glaxosmithkline Plc
F. Hoffmann-La Roche Ltd.
Merck & Co. Inc.
Novartis AG
Sanofi S.A
Pfizer Inc.
Takeda Pharmaceutical
Valeant Pharmaceuticals
Watson Pharmaceuticals, Inc.
Theratechnologies Inc.
Alnylam Pharmaceuticals, Inc.
Protagonist Therapeutics, Inc.
Dicerna Pharmaceuticals, Inc.
Endo International
Provectus Biopharmaceuticals Inc.
MAX BioPharma, Inc.
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Therapy Type
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Key Highlights
Product launch
PEST Analysis
Technological Advancements
Regulatory Scenario
Mergers and Acquisitions
4. Liver Diseases Therapeutics Market, By Therapy Type, 2019 – 2027, (US$ Mn)
Introduction
Market Share Analysis, 2020 and 2027 (%)
Y-o-Y Growth Analysis, 2017 – 2027
Segment Trends
Anti-Rejection Drugs/Immunosuppressant’s
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Chemotherapy Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Targeted therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Anti-Viral Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Immunoglobulin’s
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Corticosteroids
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
5. Liver Diseases Therapeutics Market, By Distribution Channel, 2019 – 2027, (US$ Mn)
Introduction
Market Share Analysis, 2020 and 2027 (%)
Y-o-Y Growth Analysis, 2017 – 2027
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
6. Liver Diseases Therapeutics Market, By Region, 2019 – 2027, (US$ Mn)
Introduction
Market Share Analysis, By Region, 2020 and 2027 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2026
North America
Market Size and Forecast, By Therapy Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
U.S.
Canada
Latin America
Market Size and Forecast, By Therapy Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Market Size and Forecast, By Therapy Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Therapy Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of APAC
Middle East
Market Size and Forecast, By Therapy Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Market Size and Forecast, By Therapy Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
South Africa
Central Africa
North Africa
7. Competitive Landscape
Company Profiles
Astellas Pharma Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Bristol-Myers Squibb
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Gilead Sciences
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Glaxosmithkline Plc
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
F. Hoffmann-La Roche Ltd.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Merck & Co. Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Novartis AG
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Sanofi S.A
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Pfizer Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Takeda Pharmaceutical
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Valeant Pharmaceuticals
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Watson Pharmaceuticals, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Theratechnologies Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Alnylam Pharmaceuticals, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Protagonist Therapeutics, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Dicerna Pharmaceuticals, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Endo International
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Provectus Biopharmaceuticals Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
MAX BioPharma, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
8. Section
References
Research Methodology
About us and Sales Contact
*Browse 34 market data tables and 24 figures on “Liver Diseases Therapeutics Market - Global forecast to 2027”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook